BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Babickova J, Gardlik R. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease. World J Gastroenterol 2015; 21(40): 11321-11330 [PMID: 26525290 DOI: 10.3748/wjg.v21.i40.11321]
URL: https://www.wjgnet.com/1007-9327/full/v21/i40/11321.htm
Number Citing Articles
1
Martin Maronek, Rene Link, Lubos Ambro, Roman Gardlik. Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel DiseaseCells 2020; 9(4): 1013 doi: 10.3390/cells9041013
2
Xiaoli Huang, Liang Zhong, Wei Fan, Yang Feng, Guanqing Xiong, Sha Liu, Kaiyu Wang, Yi Geng, Ping Ouyang, Defang Chen, Shiyong Yang, Lizi Yin, Lili Ji. Enteritis in hybrid sturgeon (Acipenser schrenckii♂ × Acipenser baeri♀) caused by intestinal microbiota disorderAquaculture Reports 2020; 18: 100456 doi: 10.1016/j.aqrep.2020.100456
3
V.P. Singh, S.D. Proctor, B.P. Willing. Koch's postulates, microbial dysbiosis and inflammatory bowel diseaseClinical Microbiology and Infection 2016; 22(7): 594 doi: 10.1016/j.cmi.2016.04.018
4
Ting Zhang, Bota Cui, Pan Li, Zhi He, Chuyan Long, Lu Wei, Zhaoyuan Peng, Guozhong Ji, Faming Zhang, John Green. Short-Term Surveillance of Cytokines and C-Reactive Protein Cannot Predict Efficacy of Fecal Microbiota Transplantation for Ulcerative ColitisPLOS ONE 2016; 11(6): e0158227 doi: 10.1371/journal.pone.0158227
5
Susan Mills, R. Paul Ross, Colin Hill. Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiologyFEMS Microbiology Reviews 2017; 41(Supp_1): S129 doi: 10.1093/femsre/fux022
6
Marzanna Łusiak-Szelachowska, Beata Weber-Dąbrowska, Maciej Żaczek, Jan Borysowski, Andrzej Górski. The Presence of Bacteriophages in the Human Body: Good, Bad or Neutral?Microorganisms 2020; 8(12): 2012 doi: 10.3390/microorganisms8122012
7
Bincy P. Abraham, Eamonn M.M. Quigley. Probiotics in Inflammatory Bowel DiseaseGastroenterology Clinics of North America 2017; 46(4): 769 doi: 10.1016/j.gtc.2017.08.003
8
Michelle Prosberg, Flemming Bendtsen, Ida Vind, Andreas M. Petersen, Lise L. Gluud. The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysisScandinavian Journal of Gastroenterology 2016; 51(12): 1407 doi: 10.1080/00365521.2016.1216587
9
Katarzyna Karpinska-Leydier, Jashvini Amirthalingam , Khadija Alshowaikh, Anuruddhika Iroshani Jayarathna, Divya Bala Anthony Manisha R Salibindla, Gokul Paidi, Huseyin Ekin Ergin. Correlation Between the Gut Microbiome and Immunotherapy Response in Inflammatory Bowel Disease: A Systematic Review of the LiteratureCureus 2021;  doi: 10.7759/cureus.16808
10
Jasmohan S. Bajaj, Giovanni Barbara, Herbert L. DuPont, F. Mearin, Antonio Gasbarrini, Jan Tack. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseasesDigestive and Liver Disease 2018; 50(8): 741 doi: 10.1016/j.dld.2018.04.020
11
Claudia F. Martinez de la Peña, Glen D. Armstrong, Margarita M. P. Arenas-Hernández, Roberto J. Cieza. Escherichia coli in the Americas2016; : 281 doi: 10.1007/978-3-319-45092-6_12
12
Anna Kuballa, Marco Geraci, Meredith Johnston, Dario Sorrentino. The Gut Microbial Profile of Preclinical Crohn’s Disease Is Similar to That of Healthy ControlsInflammatory Bowel Diseases 2020; 26(11): 1682 doi: 10.1093/ibd/izaa072
13
Loris Riccardo Lopetuso, Maria Ernestina Giorgio, Angela Saviano, Franco Scaldaferri, Antonio Gasbarrini, Giovanni Cammarota. Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?International Journal of Molecular Sciences 2019; 20(1): 183 doi: 10.3390/ijms20010183
14
Maciej Żaczek, Andrzej Górski, Aneta Skaradzińska, Marzanna Łusiak-Szelachowska, Beata Weber-Dąbrowska. Phage penetration of eukaryotic cells: practical implicationsFuture Virology 2019; 14(11): 745 doi: 10.2217/fvl-2019-0110
15
Yanzhi Wang, Rongrong Ren, Gang Sun, Lihua Peng, Yaping Tian, Yunsheng Yang. Pilot study of cytokine changes evaluation after fecal microbiota transplantation in patients with ulcerative colitisInternational Immunopharmacology 2020; 85: 106661 doi: 10.1016/j.intimp.2020.106661
16
Oren Ledder, Dan Turner. Antibiotics in IBD: Still a Role in the Biological Era?Inflammatory Bowel Diseases 2018; 24(8): 1676 doi: 10.1093/ibd/izy067
17
Liliam K. Harada, Erica C. Silva, Welida F. Campos, Fernando S. Del Fiol, Marta Vila, Krystyna Dąbrowska, Victor N. Krylov, Victor M. Balcão. Biotechnological applications of bacteriophages: State of the artMicrobiological Research 2018; : 38 doi: 10.1016/j.micres.2018.04.007
18
Zbigniew Kmieć, Marta Cyman, Tomasz Jerzy Ślebioda. Cells of the innate and adaptive immunity and their interactions in inflammatory bowel diseaseAdvances in Medical Sciences 2017; 62(1): 1 doi: 10.1016/j.advms.2016.09.001
19
Armelle Paule, Domenico Frezza, Marvin Edeas. Microbiota and Phage Therapy: Future Challenges in MedicineMedical Sciences 2018; 6(4): 86 doi: 10.3390/medsci6040086
20
Dongyue Li, Youlin Yang, Xunhai Yin, Yang Liu, Hongyu Xu, Yu Ni, Ping Hang, Sijia Niu, Huichao Zhang, Wenbo Ding, Hongyu Kuang. Glucagon-like peptide (GLP) -2 improved colonizing bacteria and reduced severity of ulcerative colitis by enhancing the diversity and abundance of intestinal mucosaBioengineered 2021; 12(1): 5195 doi: 10.1080/21655979.2021.1958600
21
Paloma S. Moreno, Josef Wagner, Carl D. Kirkwood, James R. Gilkerson, Caroline S. Mansfield. Characterization of the fecal virome in dogs with chronic enteropathyVeterinary Microbiology 2018; 221: 38 doi: 10.1016/j.vetmic.2018.05.020
22
Tiziana Larussa, Maria Imeneo, Francesco Luzza. Potential role of nutraceutical compounds in inflammatory bowel diseaseWorld Journal of Gastroenterology 2017; 23(14): 2483-2492 doi: 10.3748/wjg.v23.i14.2483